Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05427058

Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management

Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management: A Randomized Controlled Trial of Efficacy and Safety

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
University of Brawijaya · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study compared the efficacy and safety of superior hypogastric plexus block and ganglion impar block procedures on the management of pelvic and perineal cancer pain in patients with cervical and endometrial cancer

Detailed description

Superior hypogastric plexus block is a commonly used method for the management of pelvic and perineal pain due to cancer, this procedure uses a transdiscal approach at the level of the L5-S1 vertebrae by injecting 5 ml of 1% lidocaine + 10 ml of 96% alcohol and confirmed by C-arm. Compared with the ganglion impar block procedure using a trans-sacrococcygeal approach by injecting 4 ml of 1% lidocaine + 6 ml of 96% alcohol and confirmed by C-arm. The aim of this study was to compare the efficacy and safety of the ganglion impar block procedure against the superior hypogastric plexus block which is commonly used in the management of pelvic and perineal pain due to cervical and endometrial cancer.

Conditions

Interventions

TypeNameDescription
PROCEDURESuperior Hypogastric Plexus Blockthis procedure uses a transdiscal approach at the level of the L5-S1 vertebrae by injecting 5 ml of 1% lidocaine + 10 ml of 96% alcohol and confirmed by C-arm.
PROCEDUREGanglion Impar Blockthis procedure uses a trans-sacrococcygeal approach by injecting 4 ml of 1% lidocaine + 6 ml of 96% alcohol and confirmed by C-arm.

Timeline

Start date
2024-07-23
Primary completion
2025-09-30
Completion
2026-01-30
First posted
2022-06-22
Last updated
2025-07-10

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT05427058. Inclusion in this directory is not an endorsement.